Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCI-779 in Metastatic or Recurrent Endometrial Cancer
NCT00072176Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2004
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in endometrial cancer (EC), sponsored by National Cancer Institute. Started May 2004; status: completed.
02
Drugs
temsirolimus
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00072176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00072176.